Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Therapy With Teriparatide (Recombinant Parathyroid Hormone (1-34) on Vascular Compliance and Osteoprotegerin/RANKL

NCT00347737 is registered in ClinicalTrials.gov with Leland Graves III, MD as lead sponsor.

NCT NCT00347737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00347737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Therapy With Teriparatide (Recombinant Parathyroid Hormone (1-34) on Vascular Compliance and Osteoprotegerin/RANKL
Lead sponsor
Leland Graves III, MD
Phase
Not applicable
Overall status
Withdrawn
Start date
June 30, 2006
Completion date
May 31, 2008
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis